The Groundbreaking Potential of Cannabinoid Microdosing in Alzheimer’s Treatment
The innovative study published in the Journal of Medical Case Reports introduces a revolutionary approach to treating Alzheimer’s disease (AD) through cannabinoid microdosing. This case report focuses on a 75-year-old man with mild-stage Alzheimer’s, who underwent a 22-month treatment regimen with microdoses of a cannabis extract rich in cannabinoids. The treatment led to significant improvements … Read more